KMT2A and breast cancer: By recruiting MLL1 (lysine methyltransferase 2A, KMT2A), this lncRNA stimulates H3K4 methylation and upregulation of TIMP3 (inhibitor of metalloproteinases 3), with subsequent induction of migration and inhibition of apoptotic death, thus contributing to BC invasiveness [228].